Certificate of Analysis
| Product Name: | Monalizumab |
| Catalog Number: | M21501 |
| CAS Number: | 1228763-95-8 |
Physical and Chemical Properties
| Solubility: | N/A |
| Storage: |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
Analytical Data
| HPLC: | Shows Min ＞99% purity |
| H-NMR: | Consistent with structure |
Product Information
| Description: | Monalizumab is a first-in-class immune checkpoint inhibitor targeting natural killer cell population 2A (NKG2A). Monalizumab can be used in the study of head and neck squamous cell carcinoma (HNSCC). |
| Stability and Solubility Advice: | Information concerning product stability, particularly in solution, has rarely been reported and in most cases we can only offer a general guide. We recommend that stock solutions, once prepared, are stored aliquoted in tightly sealed vials and used within 1 month. Avoid repeated freeze and thaw cycles. Storage conditions for some special products should refer to their storage details. |